Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells 30,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $10.77, for a total value of $323,100.00. Following the sale, the insider now directly owns 1,726,097 shares in the company, valued at $18,590,064.69. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, August 22nd, Dawn Christine Maroney sold 7,074 shares of Alignment Healthcare stock. The shares were sold at an average price of $9.02, for a total transaction of $63,807.48.
• On Thursday, August 15th, Dawn Christine Maroney sold 20,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $8.70, for a total transaction of $174,000.00.
• On Friday, July 19th, Dawn Christine Maroney sold 36,700 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total transaction of $367,367.00.

Alignment Healthcare Trading Up 8.7 %

Shares of Alignment Healthcare stock opened at $11.80 on Thursday. The company’s 50-day moving average price is $10.17 and its 200-day moving average price is $8.27. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.70. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $12.36. The company has a market cap of $2.26 billion, a price-to-earnings ratio of -14.05 and a beta of 1.47.

Alignment Healthcare (NASDAQ:ALHC) last posted its earnings results on Thursday, August 1st. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.01. Alignment Healthcare had a negative return on equity of 101.10% and a negative net margin of 6.85%. The business had revenue of $681.29 million during the quarter, compared to analysts’ expectations of $637.66 million. During the same period in the previous year, the business earned ($0.15) earnings per share. The firm’s revenue was up 47.3% on a year-over-year basis. On average, equities analysts expect that Alignment Healthcare, Inc. will post -0.67 earnings per share for the current fiscal year.

Institutional Trading of Alignment Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Allspring Global Investments Holdings LLC lifted its stake in shares of Alignment Healthcare by 9.2% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 39,570 shares of the company’s stock valued at $196,000 after acquiring an additional 3,334 shares during the last quarter. Principal Financial Group Inc. bought a new stake in Alignment Healthcare in the first quarter valued at approximately $57,000. Blue Trust Inc. boosted its stake in shares of Alignment Healthcare by 47.4% during the first quarter. Blue Trust Inc. now owns 256,452 shares of the company’s stock valued at $1,272,000 after purchasing an additional 82,476 shares during the period. Vanguard Group Inc. grew its holdings in shares of Alignment Healthcare by 1.0% in the first quarter. Vanguard Group Inc. now owns 9,239,472 shares of the company’s stock worth $45,828,000 after purchasing an additional 93,262 shares during the last quarter. Finally, Hood River Capital Management LLC increased its stake in shares of Alignment Healthcare by 49.6% in the first quarter. Hood River Capital Management LLC now owns 2,920,836 shares of the company’s stock worth $14,487,000 after buying an additional 968,637 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. Stifel Nicolaus increased their price objective on Alignment Healthcare from $9.00 to $12.00 and gave the company a “buy” rating in a report on Friday, July 26th. Robert W. Baird increased their price target on Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a research note on Wednesday, August 14th. Barclays raised their price objective on Alignment Healthcare from $4.50 to $7.00 and gave the stock an “underweight” rating in a research report on Monday, August 5th. KeyCorp initiated coverage on Alignment Healthcare in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, TD Cowen increased their price target on Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a report on Tuesday, August 6th. One analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Alignment Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $9.83.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.